Symposium:
41. New and Updated Guidelines
Thursday, October 4, 2018: 10:30 AM-11:45 AM
Room: S 305-314
Co-organized by the IDSA Standards and Practice Guidelines Committee and Johns Hopkins University School of Medicine Div. of Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss diagnostic approaches to Lyme disease and evidence-based therapeutics
  • discriminate asymptomatic bacteriuria from other genitourinary infections and learn to facilitate indications for treatment and prevention of unnecessary treatment
  • recognize appropriate patients for OPAT and employ effective programmatic strategies to achieve successful treatment and best safety measures

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Microbiologists, Pharmacists, Public health practitioners, Researchers

Tracks: Trainee, Pediatric ID, Adult ID


Moderator:  Paul Auwaerter, MD, MBA, FIDSA, Johns Hopkins University School of Medicine

Presentations:
10:30 AM
140
Lyme Disease
Paul Lantos, MD, FIDSA

10:55 AM
141
Asymptomatic Bacteriuria
Lindsay Nicolle, MD, FIDSA, FSHEA

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-269-L01-P

Disclosures:

P. Auwaerter, American Lyme Disease Foundation: Board Member , None . Cempra: Consultant , Consulting fee . Johnson and Johnson: Shareholder , dividends, shareholder . IDSA: Board Member , stipend, travel reimbursements . MICROBPLEX, INC.: Grant Investigator , Research grant .

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.